Multiple Myeloma (MM) Completed Phase 4 Trials for Melphalan (DB01042)

Also known as: Myeloma Multiple / Myeloma-Multiple / Myeloma, Multiple / Multiple Myeloma(MM) / Multiple Myelomas / Multiple Myeloma / Plasma cell myelomas / Myelomatosis multiple / Peripheral plasma cell myeloma / Myelomatosis / Multiple myeloma myelomatosis / Plasma cell myeloma / Myeloma / Multiple myeloma with failed remission

IndicationStatusPhase
DBCOND0040908 (Multiple Myeloma (MM))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01731886Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple MyelomaTreatment
NCT02474563Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma